S-Alpha Therapeutics, Inc , Digital Therapeutics Start-up Raises $8 7 Million in Series A Funding apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Backers included Hana Ventures, STIC Ventures, AJU IB Investment, SJ Investment Partners, and TONY Investment.
The company intends to use funds to execute clinical trials in the US to study their development stage digital therapeutic application intended to treat eye disease.
Led by Seung Eun Choi, CEO, and Dr. Myung Joon Kim, Chief Medical Officer, S-Alpha is a digital therapeutics company with platform technologies that enable digital devices to treat different diseases. S-Alpha has a pipeline of products in the areas of ophthalmology, neuropsychiatry, cancer, and immunology.
Its lead product, SAT-001, is currently in the process of regulatory submission to start clinical studies in Korea as a therapeutic device for treating eye disease following MFDS’s guidance in June 2020.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Digital Therapeutics Startup S-Alpha Therapeutics Raises $2.7M in Seed Funding
December 16, 2020 GMT
SEOUL (BUSINESS WIRE) Dec 16, 2020
On November 20 th, S-Alpha Therapeutics (“S-Alpha” Seung Eun Choi, CEO), a digital therapeutics startup, completed a $2.7 Million USD (3 Billion KRW) seed round of funding from Hana Ventures, STIC Ventures, AJU IB Investment, SJ Investment Partners, and TONY Investment. This seed round follows an initial strategic investment from LegoChem Biosciences in February 2020.
ADVERTISEMENT
S-Alpha Therapeutics completed a $2.7 Million USD (3 Billion KRW) seed round of funding from Hana Ventures, STIC Ventures, AJU IB Investment, SJ Investment Partners, and TONY Investment. (Photo: Business Wire)